| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Maintenance therapy with certolizumab pegol for Crohn's disease. | N Engl J Med | 2007 | 4.56 |
| 2 | IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. | J Allergy Clin Immunol | 2012 | 1.46 |
| 3 | Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor. | Antimicrob Agents Chemother | 2004 | 0.79 |